Clinical Trials Browser

Has results × Laryngeal Neoplasms × pembrolizumab × Clear all

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

NCT02586207 2025-10-07

Pembrolizumab in Combination With CRT for LA-SCCHN

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Clinical Trials

Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer

Pembrolizumab in Combination With CRT for LA-SCCHN